BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Former FDA Official Joins 3D Communications' Scientific and Regulatory Advisory Board


2/14/2013 9:03:01 AM

WASHINGTON, Feb. 14, 2013 /PRNewswire/ -- 3D Communications today announced the expansion of its FDA Scientific and Regulatory Advisory Board with the appointment of Andrea Leonard-Segal, MD. Dr. Leonard-Segal is the recent Director of the Division of Nonprescription Clinical Evaluation (DNCE) in the FDA Center for Drug Evaluation and Research (CDER).

3D's Scientific and Regulatory Advisory Board provides 3D Communications with guidance and ad hoc support to help clients prepare for FDA interactions and FDA advisory committee meetings. The Board is comprised of former FDA officials, FDA advisory committee members, and doctors and scientists with extensive approval experience.

Dr. Leonard-Segal, co-founder of Andrea Leonard-Segal M.D. and Melissa Furness Consulting LLC, will offer companies scientific and regulatory assessment and strategy on drug development programs in all phases of clinical development.

"I am excited about this new chapter in my career to help companies with their drug development and submission programs," says Dr. Leonard-Segal. "I'm also looking forward to the opportunity to work on 3D's Board with such renowned FDA regulatory and advisory committee experts."

"We are honored to have Dr. Leonard-Segal on our Advisory Board," said 3D Communications co-founder Cindy DiBiasi. "She brings FDA expertise and crucial insights on current regulatory thinking and the inner workings at the FDA to our clients who are seeking product approval."

The 3D Science and Regulatory Advisory Board includes:
http://www.3dcommunications.us/who.html#Advisory

Eric Brass, MD, PhD, Board Chair
Gregory Burkhart, MD
Bruce Burlington, MD
Louis R. Cantilena, Jr., MD, PhD
William Hiatt, MD
Heidi M. Jolson, MD, MPH
Andrea Leonard-Segal, MD
Martin B. Leon, MD
Paul Waymack, MD, ScD
Janet Wittes, PhD

For more information about 3D Communications, visit www.3dcommunications.us, or call 202-236-4625.

3D Communications is a strategic communications firm that prepares companies for high-stakes regulatory presentations, meetings, and media interviews. Our expertise lies in transforming highly complex information into clear and persuasive communications. 3D's team of seasoned experts use a proven process, based on proprietary tools, to help companies succeed. Our services include strategic analysis, messaging, content development, speaker and media training, crisis management, and preparation for early and late-stage regulatory communications. For more information, visit www.3dcommunications.us.

Contact:

Cindy DiBiasi


3D Communications


202-236-4625


cdibiasi@3dcommunications.us

SOURCE 3D Communications


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->